Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML
Clinical trial NCT05473221 · UNKNOWN
Trial details
- NCT number
- NCT05473221
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2024-08-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.